Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
NCT04080271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2022-06-30
Summary
The aim of this study is to detect bone metastases by PET/CT examination in cancer patients.
Conditions
Interventions
- DEVICE
-
18F-FDG PET/CT
18F-fludeoxyglucose positron emission tomography/computed tomography
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mohamed A. Mekkawy, Prof. Dr · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-01
- Primary Completion
- 2021-11-01
- Completion
- 2021-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
NCT06455722 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
NCT00882609 ·Status: UNKNOWN ·Phase: PHASE3
-
Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer
NCT04750772 ·Status: UNKNOWN ·Phase: NA
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
NCT00414934 ·Status: UNKNOWN
-
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
NCT01501630 ·Status: COMPLETED
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)
NCT02876731 ·Status: COMPLETED ·Phase: NA
-
Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma
NCT06737835 ·Status: NOT_YET_RECRUITING
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT
NCT05614518 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC
NCT04514822 ·Status: UNKNOWN ·Phase: NA
-
Role of Positron Emission Tomography in Detecting Primary Tumor in Cases of Metastases of Unknown Origin
NCT06086652 ·Status: RECRUITING
-
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
NCT03830242 ·Status: UNKNOWN ·Phase: NA
-
Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients
NCT03924609 ·Status: COMPLETED